- $872.24m
- $6.97bn
- $864.62m
- 13
- 77
- 86
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,005 | 456 | 819 | 1,187 | 865 |
Cost of Revenue | |||||
Gross Profit | 759 | 315 | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,036 | 644 | 800 | 1,034 | 810 |
Operating Profit | -30.9 | -188 | 18.4 | 153 | 54.6 |
Net Income Before Taxes | -30.9 | -188 | 18.4 | 153 | 54.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -30.7 | -188 | 18.6 | 290 | 38.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -30.7 | -188 | 18.6 | 290 | 38.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.7 | -188 | 18.6 | 290 | 38.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.316 | -1.8 | 0.289 | 2.79 | 0.359 |